SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-220676
Filing Date
2015-06-11
Accepted
2015-06-11 16:56:58
Documents
4
Period of Report
2015-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d939823d8k.htm 8-K 35619
2 EX-3.1 d939823dex31.htm EX-3.1 5251
3 EX-3.2 d939823dex32.htm EX-3.2 87856
4 EX-99.1 d939823dex991.htm EX-99.1 236839
  Complete submission text file 0001193125-15-220676.txt   367021
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 15926573
SIC: 2834 Pharmaceutical Preparations